BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 12171513)

  • 1. L-nucleosides: antiviral activity and molecular mechanism.
    Gumina G; Chong Y; Choo H; Song GY; Chu CK
    Curr Top Med Chem; 2002 Oct; 2(10):1065-86. PubMed ID: 12171513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-nucleoside enantiomers as antivirals drugs: a mini-review.
    Mathé C; Gosselin G
    Antiviral Res; 2006 Sep; 71(2-3):276-81. PubMed ID: 16797735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-Nucleosides as chemotherapeutic agents.
    Gumina G; Song GY; Chu CK
    FEMS Microbiol Lett; 2001 Aug; 202(1):9-15. PubMed ID: 11506901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of 2',3'-dideoxy-2'-fluoro-L-threo-pentofuranosyl nucleosides as potential antiviral agents.
    Cavalcanti SC; Xiang Y; Newton MG; Schinazi RF; Cheng YC; Chu CK
    Nucleosides Nucleotides; 1999 Oct; 18(10):2233-52. PubMed ID: 10616728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of L-Fd4C and related nucleoside analogs as promising antiviral agents.
    Chen SH
    Curr Med Chem; 2002 May; 9(9):899-912. PubMed ID: 11966452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antiviral activities of enantiomeric 1-[2-(hydroxymethyl) cyclopropyl] methyl nucleosides.
    Pierra C; Olgen S; Cavalcanti SC; Cheng YC; Schinazi RF; Chu CK
    Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):253-68. PubMed ID: 10772713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The search for nucleoside/nucleotide analog inhibitors of dengue virus.
    Chen YL; Yokokawa F; Shi PY
    Antiviral Res; 2015 Oct; 122():12-9. PubMed ID: 26241002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enantioselectivity of the antiviral effects of nucleoside analogues.
    Zemlicka J
    Pharmacol Ther; 2000 Mar; 85(3):251-66. PubMed ID: 10739880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antiviral activity of oxaselenolane nucleosides.
    Chu CK; Ma L; Olgen S; Pierra C; Du J; Gumina G; Gullen E; Cheng YC; Schinazi RF
    J Med Chem; 2000 Oct; 43(21):3906-12. PubMed ID: 11052795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enantiomeric synthesis of D- and L-cyclopentenyl nucleosides and their antiviral activity against HIV and West Nile virus.
    Song GY; Paul V; Choo H; Morrey J; Sidwell RW; Schinazi RF; Chu CK
    J Med Chem; 2001 Nov; 44(23):3985-93. PubMed ID: 11689085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, anti-human immunodeficiency virus and anti-hepatitis B virus activities of novel oxaselenolane nucleosides.
    Du J; Surzhykov S; Lin JS; Newton MG; Cheng YC; Schinazi RF; Chu CK
    J Med Chem; 1997 Sep; 40(19):2991-3. PubMed ID: 9301659
    [No Abstract]   [Full Text] [Related]  

  • 12. Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.
    Delaney WE; Locarnini S; Shaw T
    Antivir Chem Chemother; 2001 Jan; 12(1):1-35. PubMed ID: 11437320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 3'-halo-5'-norcarbocyclic nucleoside phosphonates as potent anti-HIV agents.
    Hamon N; Kaci M; Uttaro JP; Périgaud C; Mathé C
    Eur J Med Chem; 2018 Apr; 150():642-654. PubMed ID: 29558735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of hepatitis B virus inhibition by novel 2'-fluoro-2',3'-unsaturated beta-D- and L-nucleosides.
    Pai SB; Pai RB; Xie MY; Beker T; Shi J; Tharnish PM; Chu CK; Schinazi RF
    Antivir Chem Chemother; 2005; 16(3):183-92. PubMed ID: 16004081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Advances in the study of nucleoside antiviral drugs].
    Liu K; Xie L
    Yao Xue Xue Bao; 2006 Aug; 41(8):689-93. PubMed ID: 17039770
    [No Abstract]   [Full Text] [Related]  

  • 16. Understanding the mode of action of L-nucleosides as antiviral agents: a molecular modeling approach.
    Lee K; Chong Y; Chu CK
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):385-8. PubMed ID: 11563052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbocyclic nucleosides (carbanucleosides) as new therapeutic leads.
    Schneller SW
    Curr Top Med Chem; 2002 Oct; 2(10):1087-92. PubMed ID: 12171514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of enantiomerically pure D- and L-bicyclo[3.1.0]hexenyl carbanucleosides and their antiviral evaluation.
    Park AY; Kim WH; Kang JA; Lee HJ; Lee CK; Moon HR
    Bioorg Med Chem; 2011 Jul; 19(13):3945-55. PubMed ID: 21658957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interplay between antiviral activity, oligonucleotide hybridisation and nucleic acids incorporation studies.
    Herdewijn P
    Antiviral Res; 2006 Sep; 71(2-3):317-21. PubMed ID: 16690140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and Antiviral Evaluation of 3'-Fluoro-5'-norcarbocyclic Nucleoside Phosphonates Bearing Uracil and Cytosine as Potential Antiviral Agents.
    Geant PY; Uttaro JP; Périgaud C; Mathé C
    Molecules; 2020 Aug; 25(16):. PubMed ID: 32823897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.